These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24710674)

  • 1. [From pathophysiology to the development of guidelines and new therapeutic strategies in schizophrenia].
    Falkai P; Reich-Erkelenz D; Schmitt A
    Fortschr Neurol Psychiatr; 2014 Apr; 82(4):186-90. PubMed ID: 24710674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of schizophrenia.
    Wasylenki DA
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S65-9. PubMed ID: 7874667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functionality and economic costs of outpatients with schizophrenia in Taiwan.
    Lee IH; Chen PS; Yang YK; Liao YC; Lee YD; Yeh TL; Yeh LL; Cheng SH; Chu CL
    Psychiatry Res; 2008 Apr; 158(3):306-15. PubMed ID: 18243334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antipsychotic agents: emerging clinical profiles.
    Buckley PF
    J Clin Psychiatry; 1999; 60 Suppl 1():12-7; discussion 28-30. PubMed ID: 10037165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome in schizophrenia: beyond symptom reduction.
    Meltzer HY
    J Clin Psychiatry; 1999; 60 Suppl 3():3-7; discussion 8. PubMed ID: 10073370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: outcomes.
    Kulkarni J; de Castella AR; Filia KM; Filia SL; Marston N; Montgomery W; Christova L; Fitzgerald PB
    Aust N Z J Psychiatry; 2007 Dec; 41(12):969-79. PubMed ID: 17999269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cognitive dysfunction in schizophrenia.
    Peuskens J; Demily C; Thibaut F
    Clin Ther; 2005; 27 Suppl A():S25-37. PubMed ID: 16198199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of the costs of treating schizophrenia in Spain: a hierarchical Bayesian approach.
    Vázquez-Polo FJ; Negrín M; Cabasés JM; Sánchez E; Haro JM; Salvador-Carulla L
    J Ment Health Policy Econ; 2005 Sep; 8(3):153-65. PubMed ID: 16278503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology of schizophrenia and its impact on pharmacotherapy].
    Widschwendter CG; Fleischhacker WW
    Fortschr Neurol Psychiatr; 2005 Nov; 73 Suppl 1():S32-7. PubMed ID: 16270242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Costs of schizophrenia - what we know (not)?].
    Salize HJ
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S21-8. PubMed ID: 11533903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: economics.
    Fitzgerald PB; Montgomery W; de Castella AR; Filia KM; Filia SL; Christova L; Jackson D; Kulkarni J
    Aust N Z J Psychiatry; 2007 Oct; 41(10):819-29. PubMed ID: 17828655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Older people with chronic schizophrenia.
    Karim S; Overshott R; Burns A
    Aging Ment Health; 2005 Jul; 9(4):315-24. PubMed ID: 16019287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing effectiveness research and improving care for schizophrenia in real-world settings.
    Buckley PF; Miller A; Chiles JA; Sajatovic M
    Am J Manag Care; 1999 Jun; 5 Spec No():SP47-56. PubMed ID: 10538860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The social and economic burden of treatment-resistant schizophrenia: a systematic literature review.
    Kennedy JL; Altar CA; Taylor DL; Degtiar I; Hornberger JC
    Int Clin Psychopharmacol; 2014 Mar; 29(2):63-76. PubMed ID: 23995856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obsessive-compulsive symptoms in schizophrenia: prevalence, clinical features and treatment. A literature review.
    Hadi E; Greenberg Y; Sirota P
    World J Biol Psychiatry; 2012 Jan; 13(1):2-13. PubMed ID: 21554025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modification of long-term schizophrenia by somato-therapeutic measures].
    Gross G; Huber G; Schüttler R
    Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.